Prosight Management, LP
ProSight Management, LP is a hedge fund based in Dallas, Texas, United States. Registered in Delaware and operating since at least 2014, it manages investment portfolios, primarily for institutional clients. The firm is small, with approximately 5 employees, all of whom are directly focused on investments.
Investment Strategy
ProSight Management, LP typically employs a fundamental, value-oriented long/short equity investment strategy, focusing on deep research and concentrated positions in both public and private companies. The firm seeks to generate significant risk-adjusted returns through active portfolio management and opportunistic investments, often in sectors such as healthcare and technology.
Latest 13F Filing Activity
Prosight Management, LP filed their most recent 13F report on Jun 30, 2025 disclosing 39 equity positions with a total 13F market value of $410M. The fund increased holdings in Unitedhealth Group Inc., Galapagos NV, Adc Therapeutics SA among other positions. Prosight Management, LP reduced exposure to Schrodinger Inc., Intuitive Surgical Inc., Abcellera Biologics Inc. among others.
Top Holdings
Equity Positions (39)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
G GLPG | GALAPAGOS NV | 12.11% | $49.6M | 1,773,649 | $33.24 | $27.99 | +$16.6M |
U UNH | UNITEDHEALTH GROUP INC | 8.37% | $34.3M | 110,000 | $311.97 | $311.97 | +$34.3M |
M MGTX | MEIRAGTX HLDGS PLC | 7.29% | $29.9M | 4,587,423 | $6.80 | $6.52 | +$4.9M |
A ADCT | ADC THERAPEUTICS SA | 6.84% | $28.1M | 10,467,771 | $2.68 | $2.68 | +$14.6M |
B BBIO | BRIDGEBIO PHARMA INC | 4.98% | $20.4M | 472,687 | $27.86 | $43.18 | -$677.1K |